Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
- 1 November 1997
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 350 (9088), 1349-1353
- https://doi.org/10.1016/s0140-6736(97)06031-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.Heart, 1994
- Fortnightly Review: Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?BMJ, 1994
- Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.Heart, 1993
- Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarctionThe Lancet, 1993
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.Journal of Clinical Investigation, 1991
- Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).Circulation, 1990
- Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.Journal of Clinical Investigation, 1986
- Physician practice in the management of congestive heart failureJournal of the American College of Cardiology, 1986
- Plasma alpha natriuretic peptide in cardiac impairment.BMJ, 1986
- Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the HumanScience, 1986